Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials
- Lorenzetti, R
- Zullo, A
- Ridola, L
- Diamanti, Ap
- Laganà
- Gatta, L
- Migliore, A
- Armuzzi, Alessandro (ORCID:0000-0003-1572-0118)
- Hassan, C
- Bruzzese, V.
DOIAbstract
Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies
Add to ORKG